Lorviqua Den Europæiske Union - dansk - EMA (European Medicines Agency)

lorviqua

pfizer europe ma eeig - lorlatinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Orserdu Den Europæiske Union - dansk - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Lapatinib "Newbury" 250 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

lapatinib "newbury" 250 mg filmovertrukne tabletter

newbury pharmaceuticals ab - lapatinibditosylatmonohydrat - filmovertrukne tabletter - 250 mg

Erlotinib "Stada" 100 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "stada" 100 mg filmovertrukne tabletter

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 100 mg

Erlotinib "Stada" 150 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "stada" 150 mg filmovertrukne tabletter

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 150 mg

Erlotinib "Stada" 25 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "stada" 25 mg filmovertrukne tabletter

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 25 mg